The Germany-based biopharmaceutical company, Vivoryon Therapeutics, is dedicated to researching and developing therapeutic products for Alzheimer's disease and cancer. Their pipeline includes PQ912, PQ1565, and PQ-family. By leveraging their in-depth understanding of pathologic pathways, they aim to create small molecule medications that improve the lives of those affected by severe diseases.